Medicare coverage notice
This article was originally published in The Gray Sheet
Executive Summary
Request for a 30-day extension of the comment period on the Health Care Financing Administration's May 16 "notice of intent" on Medicare coverage criteria is filed by seven device industry associations, including the American Electronics Association, the Health Industry Manufacturers Association, the Indiana Medical Device Manufacturers Council, the Massachusetts Medical Device Industry Council, Medical Alley, the Medical Device Manufacturers Association, and the National Electrical Manufacturers Association. The comment period for the notice expires June 15
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.